Success Story: Advancing Precision Medicine in Breast Oncology—An NIW Approval for an Indian Chief Resident Physician

 

Client’s Testimonial:

“My experience working with Chen immigration team on my immigration process has been phenomenal. Their expertise in Green card matters, particularly with EB2 NIW and EB1 categories, is truly exceptional. They have an in-depth understanding of the nuances involved, especially for physicians, which made a significant difference in my case. Chen and the team were thorough, highly responsive, and never took shortcuts. They consistently delivered more than promised and ensured every step was handled with precision and care. Thanks to their guidance, my NIW application was filed smoothly and approved quickly after upgrading to Premium.

Because of this outstanding experience, I am moving forward with Chen and the team for my EB1 processing as well. Their professionalism and commitment have earned my complete trust, and I highly recommend them to anyone seeking reliable immigration support.”


On January 9th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Chief Resident Physician in the field of Breast Oncology (Approval Notice).


General Field: Breast Oncology

Position at the Time of Case Filing: Chief Resident Physician

Country of Origin: India

State of Residence at the Time of Case Filing: California

Approval Notice Date: January 9th, 2026

Processing Time: 2 months, 24 days (Premium Processing Upgrade Requested)


Case Summary:  

Precision in cancer treatment is not just about saving lives; it is about preserving the quality of life. This success story features a chief resident physician from India whose research is transforming how clinicians manage breast cancer progression.

With an M.B.B.S. and extensive training in surgical oncology, she focuses on identifying specific genomic markers and tumor microenvironmental determinants. Her work addresses a critical dilemma in the medical community: distinguishing between high-risk patients who need immediate intervention and low-risk patients who can safely opt for non-surgical “watchful waiting”.

The client’s research is vital to the United States because it tackles the heavy burden of breast cancer while aiming to reduce unnecessary surgeries. By elucidating these biological drivers, her work not only facilitates the development of new immune-based treatments but also supports broader national health initiatives designed to improve patient outcomes and ensure equal access to effective care.

To support the National Interest Waiver (NIW) petition, the case highlighted her impressive objective credentials and the influence of her work. She has authored 15 peer-reviewed journal articles, 9 abstracts and 1 preprint, which had garnered 107 citations at the time of filing. Notably, one of her articles ranked in the top 1% of most-cited articles in Clinical Medicine for its publication year, demonstrating the high utility of her findings. Additionally, her research has been supported by major funding sources, including the National Cancer Institute and the University of California, San Francisco’s Resource Allocation Program, further validating its national significance.

North America Immigration Law Group (NAILG) successfully demonstrated that the client is well-positioned to advance this critical endeavor and that her work offers substantial benefits to the U.S. healthcare system. The petition emphasized that her contributions extend beyond her immediate employment, benefiting the wider academic and medical communities. As a result, the case was approved on January 9, 2026, in just 2 months and 24 days via Premium Processing, securing a path for this talented researcher to continue her impactful work in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.


Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)
Category Approval or Refund® Approval or RefilingTM
Approved Sum Success Rate Approved Sum Success Rate
NIW 28,946 99.52% 3,030 98.31%
EB1A 4,322 91.76% 2,870 88.91%
EB1B 793 98.51% 236 90.77%
Total 34,061 98.44% 6,136 93.39%


Approval Notices: https://www.wegreened.com/eb1_niw_approvals

Success Stories: https://www.wegreened.com/blog/

Website: www.wegreened.com

Free evaluation: https://www.wegreened.com/Free-Evaluation

Tel: 888.666.0969 (Toll Free)


To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE


Copyright © North America Immigration Law GroupWeGreened.com, All Rights Reserved.